<DOC>
	<DOCNO>NCT02407288</DOCNO>
	<brief_summary>The purpose study determine whether tDCS effective add-on treatment SSRI-resistant patient obsessive compulsive disorder</brief_summary>
	<brief_title>tDCS add-on Treatment SSRI-resistant OCD</brief_title>
	<detailed_description>Total number schedule patient recruit : 46 We use effect size study Ruffini colleague ( 2009 ) rTMS use target leave orbito frontal cortex calculate number patient recruit . With risk alpha 5 % , power 80 % , number patient include 46 anticipated rate 10 % lose follow-up patient . ( calculation make http : //www.spc.univ-lyon1.fr/mfcalc/NSN/assistant.htm ) Statistical analysis address primary secondary objective : Chi square test applied quantitative data .</detailed_description>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<criteria>patient diagnose OCD accord DSM V criterion YBOCS score 16 , stable ( &lt; 20 % variation ) least one month . receive least 12 week 6 week either maximum tolerate dose alternatively manufacturer 's recommended maxi mum daily dose . age 18 70 voluntary competent consent Major depressive disorder diagnose DSM V criterion MADRS score &gt; 30 ( actual ) schizophrenia psychotic disorder drug alcohol abuse acutely suicidal significant head injury , neurosurgical procedure implant material pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>OCD</keyword>
</DOC>